These results, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the principle of focusing on ACKR3 as a unique solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Conditions. By ticking this box https://waynel405evm2.weblogco.com/profile